Nice Timothy J, Baldridge Megan T, McCune Broc T, Norman Jason M, Lazear Helen M, Artyomov Maxim, Diamond Michael S, Virgin Herbert W
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Science. 2015 Jan 16;347(6219):269-73. doi: 10.1126/science.1258100. Epub 2014 Nov 27.
Norovirus gastroenteritis is a major public health burden worldwide. Although fecal shedding is important for transmission of enteric viruses, little is known about the immune factors that restrict persistent enteric infection. We report here that although the cytokines interferon-α (IFN-α) and IFN-β prevented the systemic spread of murine norovirus (MNoV), only IFN-λ controlled persistent enteric infection. Infection-dependent induction of IFN-λ was governed by the MNoV capsid protein and correlated with diminished enteric persistence. Treatment of established infection with IFN-λ cured mice in a manner requiring nonhematopoietic cell expression of the IFN-λ receptor, Ifnlr1, and independent of adaptive immunity. These results suggest the therapeutic potential of IFN-λ for curing virus infections in the gastrointestinal tract.
诺如病毒胃肠炎是全球主要的公共卫生负担。尽管粪便排放在肠道病毒传播中很重要,但对于限制肠道持续性感染的免疫因素却知之甚少。我们在此报告,虽然细胞因子干扰素-α(IFN-α)和干扰素-β可防止鼠诺如病毒(MNoV)的全身扩散,但只有干扰素-λ能控制肠道持续性感染。干扰素-λ的感染依赖性诱导由MNoV衣壳蛋白控制,并与肠道持续性减弱相关。用干扰素-λ治疗已建立的感染可治愈小鼠,其方式需要干扰素-λ受体Ifnlr1在非造血细胞中表达,且独立于适应性免疫。这些结果表明干扰素-λ在治疗胃肠道病毒感染方面具有潜在的治疗价值。